PD-L1hi B cells are critical regulators of humoral immunity

Nature Communications

Volumn 6, Issue , 2015, Pages

  Khan, Adnan R ^a   Hams, Emily ^a   Floudas, Achilleas ^a   Sparwasser, Tim ^b   Weaver, Casey T ^c   Fallon, Padraic G ^a,d  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b INSTITUTE OF INFECTION IMMUNOLOGY   (Germany)

^c University of Alabama at Birmingham   (United States)

^d OUR LADY S CHILDREN S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL ACTIVATING FACTOR RECEPTOR; B CELL MATURATION ANTIGEN; CD4 ANTIGEN; CHEMOKINE RECEPTOR CXCR5; PROGRAMMED DEATH 1 RECEPTOR; RITUXIMAB; BLR1 PROTEIN, MOUSE; CD274 PROTEIN, HUMAN; CD274 PROTEIN, MOUSE; CXCR5 PROTEIN, HUMAN; CYTOKINE; IMMUNOGLOBULIN G; INTERLEUKIN 10; MONOCLONAL ANTIBODY; PDCD1 PROTEIN, HUMAN; PDCD1 PROTEIN, MOUSE; PROGRAMMED DEATH 1 LIGAND 1;

ADOPTIVE TRANSFER; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELL ACTIVITY; CELL DIFFERENTIATION; CELL EXPANSION; CELL FUNCTION; CELL TRANSFER; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; HUMORAL IMMUNE DEFICIENCY; HUMORAL IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; NONHUMAN; NORMAL HUMAN; PROTEIN EXPRESSION; ANIMAL; AUTOIMMUNITY; BIOSYNTHESIS; C57BL MOUSE; CD4+ T LYMPHOCYTE; CELL SEPARATION; CHEMISTRY; CYTOLOGY; HOMEOSTASIS; IMMUNE SYSTEM; IMMUNOLOGY; INFLAMMATION; METABOLISM; PHYSIOLOGY; YOUNG ADULT;

ADULT; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD274; AUTOIMMUNITY; B-LYMPHOCYTES, REGULATORY; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL SEPARATION; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; HOMEOSTASIS; HUMANS; IMMUNE SYSTEM; IMMUNITY, HUMORAL; IMMUNOGLOBULIN G; INFLAMMATION; INTERLEUKIN-10; MICE; MICE, INBRED C57BL; PROGRAMMED CELL DEATH 1 RECEPTOR; RECEPTORS, CXCR5; YOUNG ADULT;

EID: 84930418220     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms6997     Document Type: Article

References (69)

1. + phenotype controls T cell-dependent inflammatory responses. Immunity 28, 639-650 (2008).
2. Mauri, C. Regulation of immunity and autoimmunity by B cells. Curr. Opin. Immunol. 22, 761-767 (2010).
3. Yanaba, K. et al. Regulatory B cells suppress imiquimod-induced, psoriasis-like skin inflammation. J. Leukoc. Biol. 94, 1-11 (2013).
4. King, C., Tangye, S. G. & Mackay, C. R. T follicular helper (TFH) cells in normal and dysregulated immune responses. Annu. Rev. Immunol. 26, 741-766 (2008).
5. Crotty, S. Follicular helper CD4 T cells (TFH). Annu. Rev. Immunol. 29, 621-663 (2011).
6. Ma, C. S., Deenick, E. K., Batten, M. & Tangye, S. G. The origins, function, and regulation of T follicular helper cells. J. Exp. Med. 209, 1241-1253 (2012).
7. Cubas, R. a. et al. Inadequate T follicular cell help impairs B cell immunity during HIV infection. Nat. Med. 19, 494-499 (2013).
8. Chang, P.-P. et al. Identification of Bcl-6-dependent follicular helper NKT cells that provide cognate help for B cell responses. Nat. Immunol. 13, 35-43 (2012).
9. Xu, H. et al. Follicular T-helper cell recruitment governed by bystander B cells and ICOS-driven motility. Nature 496, 523-527 (2013).
10. Liu, X. et al. Transcription factor achaete-scute homologue 2 initiates follicular T-helper-cell development. Nature 507, 513-518 (2014).
11. + T cells indicate Tfh cell activity and promote antibody responses upon antigen reexposure. Immunity 39, 770-781 (2013).
12. + memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses. Immunity 39, 758-769 (2013).
13. Fife, B. T. & Pauken, K. E. The role of the PD-1 pathway in autoimmunity and peripheral tolerance. Ann. NY Acad. Sci. 1217, 45-59 (2011).
14. Francisco, L. M. et al. PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J. Exp. Med. 206, 3015-3029 (2009).
15. Good-Jacobson, K. L. et al. PD-1 regulates germinal center B-cell survival and the formation and affinity of long-lived plasma cells. Nat. Immunol. 11, 535-542 (2010).
16. Hams, E. et al. Blockade of B7-H1 (programmed death ligand 1) enhances humoral immunity by positively regulating the generation of T follicular helper cells. J. Immunol. 186, 5648-5655 (2011).
17. Linterman, M. a. et al. Foxp3 + follicular regulatory T cells control the germinal center response. Nat. Med. 17, 975-982 (2011).
18. Sage, P. T., Francisco, L. M., Carman, C. V. & Sharpe, A. H. The receptor PD-1 controls follicular regulatory T cells in the lymph nodes and blood. Nat. Immunol. 14, 152-161 (2013).
19. Kim, H., Verbinnen, B., Tang, X., Lu, L. & Cantor, H. Inhibition of follicular T-helper cells by CD8 1 regulatory T cells is essential for self tolerance. Nature 467, 328-332 (2010).
20. Tangye, S., Ma, C., Brink, R. & Deenick, E. The good, the bad and the ugly TFH cells in human health and disease. Nat. Rev. Immunol. 13, 412-426 (2013).
21. Evans, J. G. et al. Novel suppressive function of transitional 2 B cells in experimental arthritis. J. Immunol. 178, 7868-7878 (2007).
22. Mauri, C. & Bosma, A. Immune regulatory function of B cells. Annu. Rev. Immunol. 30, 221-241 (2012).
23. Amu, S. et al. Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model. J. Allergy Clin. Immunol. 125, 1114-1124.e8 (2010).
24. Pelletier, N. et al. Plasma cells negatively regulate the follicular helper T cell program. Nat. Immunol. 11, 1110-1118 (2010).
25. Doi, T. et al. IgA plasma cells express the negative regulatory co-stimulatory molecule programmed cell death 1 ligand and have a potential tolerogenic role in the intestine. Biochem. Biophys. Res. Commun. 425, 918-923 (2012).
26. Kallies, A. et al. Plasma cell ontogeny defined by quantitative changes in blimp-1 expression. J. Exp. Med. 200, 967-977 (2004).
27. Fooksman, D. R., Nussenzweig, M. C. & Dustin, M. L. Myeloid cells limit production of antibody-secreting cells after immunization in the lymph node. J. Immunol. 192, 1004-1012 (2014).
28. Maynard, C. L. et al. Regulatory T cells expressing interleukin 10 develop from Foxp3 + and Foxp3 - precursor cells in the absence of interleukin 10. Nat. Immunol. 8, 931-941 (2007).
29. Haynes, N. M. et al. Role of CXCR5 and CCR7 in follicular Th cell positioning and appearance of a programmed cell death gene-1high germinal center-associated subpopulation. J. Immunol. 179, 5099-5108 (2007).
30. Yoshizaki, A. et al. Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature 491, 264-268 (2012).
31. Blair, P. A. et al. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity 32, 129-140 (2010).
32. Lahl, K. et al. Selective depletion of Foxp3 + regulatory T cells induces a scurfy-like disease. J. Exp. Med. 204, 57-63 (2007).
33. Vaeth, M. et al. Follicular regulatory T cells control humoral autoimmunity via NFAT2-regulated CXCR5 expression. J. Exp. Med. 211, 545-561 (2014).
34. Chung, Y. et al. Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions. Nat. Med. 17, 983-988 (2011).
35. Wilson, M. S. et al. Helminth-induced CD19 + CD23hi B cells modulate experimental allergic and autoimmune inflammation. Eur. J. Immunol. 40, 1682-1696 (2010).
36. Lund, F. E. & Randall, T. D. Effector and regulatory B cells: modulators of CD4(+) T cell immunity. Nat. Rev. Immunol. 10, 236-247 (2010).
37. Kuchroo, V. K. et al. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. J. Immunol. 151, 4371-4382 (1993).
38. Park, H. et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133-1141 (2005).
39. Rothhammer, V. et al. Th17 lymphocytes traffic to the central nervous system independently of α4 integrin expression during EAE. J. Exp. Med. 208, 2465-2476 (2011).
40. McGeachy, M. J., Stephens, L. a. & Anderton, S. M. Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4 + CD25 + regulatory cells within the central nervous system. J. Immunol. 175, 3025-3032 (2005).
41. Rolf, J., Fairfax, K. & Turner, M. Signaling pathways in T follicular helper cells. J. Immunol. 184, 6563-6568 (2010).
42. Liao, W., Lin, J.-X., Wang, L., Li, P. & Leonard, W. J. Modulation of cytokine receptors by IL-2 broadly regulates differentiation into helper T cell lineages. Nat. Immunol. 12, 551-559 (2011).
43. Zielinski, C. E. et al. Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1b. Nature 484, 514-518 (2012).
44. Yang, X.-P. et al. Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5. Nat. Immunol. 12, 247-254 (2011).
45. Kaplan, M. H. et al. STAT3-dependent IL-21 production from T helper cells regulates hematopoietic progenitor cell homeostasis. Blood 117, 6198-6201 (2011).
46. Ma, C. S. et al. Functional STAT3 deficiency compromises the generation of human T follicular helper cells. Blood 119, 3997-4008 (2012).
47. Johnston, R. J., Choi, Y. S., Diamond, J. A., Yang, J. A. & Crotty, S. STAT5 is a potent negative regulator of TFH cell differentiation. J. Exp. Med. 209, 243-250 (2012).
48. Mössner, E. et al. Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell-mediated B-cell cytotoxicity. Blood 115, 4393-4402 (2010).
49. Barr, T. A. et al. B-cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells. J. Exp. Med. 209, 1001-1010 (2012).
50. Hauser, S. L. et al. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. New Engl. J. Med. 358, 676-688 (2008).
51. Baumjohann, D. et al. Persistent antigen and germinal center B cells sustain T follicular helper cell responses and phenotype. Immunity 38, 596-605 (2013).
52. Claudio, E., Brown, K., Park, S., Wang, H. & Siebenlist, U. BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells. Nat. Immunol. 3, 958-965 (2002).
53. Mackay, F. & Schneider, P. Cracking the BAFF code. Nat. Rev. Immunol. 9, 491-502 (2009).
54. Kreuzaler, M. et al. Soluble BAFF levels inversely correlate with peripheral B cell numbers and the expression of BAFF receptors. J. Immunol. 188, 497-503 (2012).
55. Lin, W. Y. et al. Anti-BR3 antibodies: a new class of B-cell immunotherapy combining cellular depletion and survival blockade. Blood 110, 3959-3967 (2007).
56. Sarantopoulos, S. et al. Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host disease. Blood 117, 2275-2283 (2011).
57. Pollard, R. P. E. et al. Serum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjogren's syndrome: data from a placebo-controlled clinical trial. Ann. Rheum. Dis. 72, 146-148 (2013).
58. Morita, R. et al. Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity 34, 108-121 (2011).
59. Hamel, K. M. et al. B7-H1 expression on non-B and non-T cells promotes distinct effects on T- and B-cell responses in autoimmune arthritis. Eur. J. Immunol. 40, 3117-3127 (2010).
60. Wang, R.-X. et al. Interleukin-35 induces regulatory B cells that suppress autoimmune disease. Nat. Med. 20, 633-641 (2014).
61. Rosser, E. C., Blair, P. A. & Mauri, C. Cellular targets of regulatory B cell-mediated suppression. Mol. Immunol. 62, 296-304 (2014).
62. Okazaki, T., Chikuma, S., Iwai, Y., Fagarasan, S. & Honjo, T. A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application. Nat. Immunol. 14, 1212-1218 (2013).
63. Nurieva, R. I. et al. STAT5 protein negatively regulates T follicular helper (Tfh) cell generation and function. J. Biol. Chem. 287, 11234-11239 (2012).
64. Wong, M., La Cava, A. & Hahn, B. H. Blockade of programmed death-1 in young (New Zealand Black x New Zealand White)F1 mice promotes the suppressive capacity of CD4+ regulatory T cells protecting from lupus-like disease. J. Immunol. 190, 5402-5410 (2013).
65. Horikawa, M., Minard-Colin, V., Matsushita, T. & Tedder, T. F. Regulatory B cell production of IL-10 inhibits lymphoma depletion during CD20 immunotherapy in mice. J. Clin. Invest. 121, 4268-4280 (2011).
66. Bossen, C. & Schneider, P. BAFF, APRIL and their receptors: structure, function and signaling. Semin. Immunol. 18, 263-275 (2006).
67. Smith, M. R., Jin, F. & Joshi, I. Enhanced efficacy of therapy with antisense BCL-2 oligonucleotides plus anti-CD20 monoclonal antibody in scid mouse/human lymphoma xenografts. Mol. Cancer Ther. 3, 1693-1699 (2004).
68. Dong, H. et al. B7-H1 determines accumulation and deletion of intrahepatic CD8 + T lymphocytes. Immunity 20, 327-336 (2004).
69. Downer, E. J. et al. Identification of the synthetic cannabinoid R(+)WIN55,212-2 as a novel regulator of IFN regulatory factor 3 activation and IFN-beta expression: relevance to therapeutic effects in models of multiple sclerosis. J. Biol. Chem. 286, 10316-10328 (2011).